National Buildings share price has zoomed 7% and is presently trading at Rs 152.9.
Meanwhile, the BSE REALTY index is at 8,582.1 (up 1.3%).
Among the top gainers in the BSE REALTY index today are MAHINDRA LIFESPACE (up 3.2%) and PRESTIGE ESTATES (up 2.5%).
Over the last one year, National Buildings has moved up from Rs 42.6 to Rs 152.9, registering a gain of Rs 110.3 (up 259.0%).
On the other hand, the BSE REALTY index has moved up from 4,051.3 to 8,582.1, registering a gain of 111.8% during the last 12 months.
The top gainers among the BSE REALTY index stocks during this same period were Sobha (up 279.6%), PRESTIGE ESTATES (up 258.7%) and Brigade Enterprises (up 142.6%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 76,700.4 (up 0.3%).
The top gainers among the BSE Sensex today are L&T (up 2.2%) and Tata Motors (up 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 23,340.6 (up 0.4%). ONGC and L&T are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,143.0 to 76,700.4, registering a gain of 13,557.4 points (up 21.5%).
National Buildings net profit grew 24.3% YoY to Rs 1,414 million for the quarter ended March 2024, compared to a profit of Rs 1,137 million a year ago. Net sales rose 43.0% to Rs 40,245 million during the period as against Rs 28,134 million in January-March 2023.
For the year ended March 2023, National Buildings reported 16.8% increase in net profit to Rs 2,780 million compared to net profit of Rs 2,379 million during FY22. Revenue of the company grew 13.8% to Rs 87,544 million during FY23.
The current Price to earnings ratio of National Buildings, based on rolling 12 month earnings, stands at 66.4.
Equitymaster requests your view! Post a comment on "National Buildings Gains 7%; BSE REALTY Index Up 1.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!